T2 Biosystems, Inc.

In its fiscal year 2022 Inpatient Prospective Payment System (IPPS) final rule posted 2 August, CMS acknowledged the unprecedented impact of COVID-19 in updating Medicare payment policies and qualit

Summit Therapeutics PLC says the goal for its novel antibiotics is to “cure the patient and keep them cured.” Under that banner, the company's ridinilazole, its Phase III candidate for Clostridium d

Atlas Genetics Ltd. has appointed Marc Jones chief operating officer and chief financial officer. Jones will be reunited with former colleague, Jeffrey Luber, Atlas' recently appointed CEO. Both Lub

The fight against infectious disease presents a revealing truth to medical practice: as hard as it is to understand the intricate variations in the life cycle of a single pathogen, it is harder still